| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2014 | Aug 15, 2014 | Protalix BioTherapeutics, Inc. | Director | Sell | 15.0 | -4,400,000 | -30.42% | ✗ | $10.9M |
| Sep 27, 2011 | Oct 5, 2011 | ORAMED PHARMACEUTICALS INC. | 10% Owner | Sell | 22.5 | -350,000 | -5.04% | ✗ | $98K |
| Sep 27, 2011 | Sep 28, 2011 | ORAMED PHARMACEUTICALS INC. | 10% Owner | Sell | 22.5 | -350,000 | -5.04% | ✗ | $98K |
| Mar 31, 2011 | Apr 4, 2011 | ORAMED PHARMACEUTICALS INC. | 10% Owner | Buy | 97.5 | +781,250 | 12.15% | ✗ | $250K |